119
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Selected ebselen analogs reduce mechlorethamine toxicity in vitro

, &
Pages 32-41 | Received 16 Jan 2013, Accepted 08 Apr 2013, Published online: 04 Jun 2013

References

  • Saladi RN, Smith E, Persaud AN. Mustard: a potential agent of chemical warfare and terrorism. Clin Exp Dermatol 2006;31:1–5
  • Duchovic R, Vilensky J. Mustard gas: its pre-World War I history. J Chem Educ 2007;84:944--948
  • Borak J, Sidell FR. Agents of chemical warfare: sulfur mustard. Ann Emerg Med 1992;21:303–308
  • Greenfield RA, Brown BR, Hutchins JB, et al. Microbiological, biological, and chemical weapons of warfare and terrorism. Am J Med Sci 2002;323:326–340
  • Korkmaz A, Yaren H, Topal T. Molecular targets against mustard toxicity: implication of cell surface receptors, peroxynitrate production, and PARP activation. Arch Toxicol 2006;80:662–670
  • Fox M, Scott D. The genetic toxicology of nitrogen and sulphur mustard. Mutat Res 1980;75:131–168
  • Karacsonyi C, Shanmugam N, Kagan E. A clinically relevant in vitro model for evaluating the effects of aerosolized vesicants. Toxicol Lett 2009;185:38–44
  • Kenar L, Boyunaga H, Serdar M, et al. Effect of nitrogen mustard, a vesicant agent, on lymphocyte energy metabolism. Clin Chem Lab Med 2006;44:1253–1257
  • Pino M, Billack B. Reduction of vesicant toxicity by butylated hydroxyanisole in A-431 skin cells. Cut Ocular Tox 2008;27:1–12
  • Gordon MK, Desantis A, Deshmukh M, et al. Doxycycline hydrogels as a potential therapy for ocular vesicant injury. J Ocul Pharmacol Ther 2010;26:407–419
  • Anumolu SS, Menjoge AR, Deshmukh M, et al. Doxycycline hydrogels with reversible disulfide crosslinks for dermal wound healing of mustard injuries. Biomaterials 2011;32:1204–1217
  • Casillas, RP, Kiser RC, Truxall JA, et al. Therapeutic approaches to dermatotoxicity by sulfur mustard. Modulation of sulfur mustard-induced injury in the mouse ear vesicant model. J Appl Toxicol 2000;20:S145–S151
  • Shakarjian MP, Heck DE, Gray JP, et al. Mechanisms mediating the vesicant actions of sulfur mustard after cutaneous exposure. Toxicol Sci 2010;114:5–19
  • Hardej D, Billack, B. Ebselen protects brain, skin, lung and blood cells from mechlorethamine toxicity. Tox Ind Health 2007;23:209–221
  • Müller A, Cadenas E, Graf P, Sies H. A novel biologically active seleno-organic compound – I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (Ebselen). Biochem Pharmacol 1984;33:3235–3239
  • Schewe T. Molecular actions of ebselen – an antiinflammatory antioxidant. Gen Pharmacol 1995;26:1153–1169
  • Konorev EA, Kennedy MC, Kalyanaraman B. Cell-permeable superoxide dismutase and glutathione peroxidase mimetics afford superior protection against doxorubicin-induced cardiotoxicity: the role of reactive oxygen and nitrogen intermediates. Arch Biochem Biophys 1999;368:421–428
  • Zhao R, Masayasu H, Holmgren A. Ebselen: a substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thioredoxin oxidant. Proc Nat Acad Sci 2002;99:8579–8584
  • Chan G, Hardej D, Santoro M, et al. Evaluation of the antimicrobial activity of ebselen: role of the yeast plasma membrane H+-ATPase. J Biochem Mol Toxicol 2007;21:252–264
  • Nozawa R, Yokota T, Fujimoto T. Susceptibility of methicillin-resistant Staphylococcus aureus to the selenium containing compound 2-phenyl,1,2-benzoisoselenazol-3(2H)-one (PZ51). Antimicrob Agents Chemother 1989;33:1388–1390
  • Wojtowicz H, Kloc K, Maliszewska I, et al. Azaanalogues of ebselen as antimicrobial and antiviral agents: synthesis and properties. Farmaco 2004;59:863–868
  • Miorelli ST, Rosa RM, Moura DJ, et al. Antioxidant and anti-mutagenic effects of ebselen in yeast and in cultured mammalian V79 cells. Mutagenesis 2008;23:93–99
  • Puntel RL, Roos DH, Folmer V, et al. Mitochondrial dysfunction induced by different organochalchogens is mediated by thiol oxidation and is not dependent of the classical mitochondrial permeability transition pore opening. Toxicol Sci 2010;117:133–143
  • Wagner G, Schuch G, Akerboom TP, Sies H. Transport of ebselen in plasma and its transfer to binding sites in the hepatocyte. Biochem Pharmacol 1994;48:1137–1144
  • Nozawa R, Arai M, Kuroto R, et al. Susceptibility of mice to bacterial and fungal infections after intragastric administration of ebselen. J Pharm Pharmacol 1996;48:64–67
  • Shah SJ, Sylvester PW. Gamma-tocotrienol inhibits neoplastic mammary epithelial cell proliferation by decreasing Akt and nuclear factor kappaB activity. Exp Biol Med 2005;230:235–241
  • Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978;52:302–310
  • Sies H. Ebselen, a selenoorganic compound as glutathione peroxidase mimic. Free Radic Biol Med 1993;14:313–323
  • Nakamura Y, Feng Q, Kumagai T, et al. Ebselen, a glutathione peroxidase mimetic seleno-organic compound, as a multifunctional antioxidant. Implication for inflammation-associated carcinogenesis. J Biol Chem 2002;277:2687–2694
  • Antony S, Bayse CA. Modeling the mechanism of the glutathione peroxidase mimic ebselen. Inorg Chem 2011;50:12075–12084
  • Olm E, Fernandes AP, Hebert C, et al. Extracellular thiol-assisted selenium uptake dependent on the x(c)-cystine transporter explains the cancer-specific cytotoxicity of selenite. Proc Natl Acad Sci 2009;106:11400–11405
  • Graham JS, Stevenson RS, Mitcheltree LW, et al. Medical management of cutaneous sulfur mustard injuries. Toxicology 2009;263:47–58
  • Bhat KR, Benton BJ, Rosenthal DS, et al. Role of poly(ADP-ribose) polymerase (PARP) in DNA repair in sulfur-mustard exposed normal human epidermal keratinocytes (NHEK). J Appl Toxicol 2000;20:S13–S17
  • Kehe K, Balszuweit F, Steinritz D, Thiermann H. Molecular toxicology of sulfur mustard-induced cutaneous inflammation and blistering. Toxicology 2009;263:12–19
  • Kanda N, Watanabe S. Cyclooxygenase-2 inhibitor enhances whereas prostaglandin E2 inhibits the production of interferon-induced protein of 10 kDa in epidermoid carcinoma A431. Invest Dermatol 2002;119:1080–1089
  • Lazarova Z, Domloge-Hultsch N, Yancey KB. Epiligrin is decreased in papulonodular basal cell carcinoma tumor nest basement membranes and the extracellular matrix of transformed human epithelial cells. Exp Dermatol 1995;4:121–129
  • Ren ZP, Ponten F, Nister M, Ponten J. Two distinct p53 immunohistochemical patterns in human squamous-cell skin cancer, precursors and normal epidermis. Int J Cancer 1996; 69:174–179
  • Kim SJ, Park C, Han AL, et al. Ebselen attenuates cisplatin-induced ROS generation through Nrf2 activation in auditory cells. Hear Res 2009;251:70–82
  • Sakuri T, Kanayama M, Shibata T, et al. Ebselen, a seleno-organic antioxidant, as an electrophile. Chem Res Toxicol 2006;19:1196–1204
  • Maiorino M, Roveri A, Ursini F. Antioxidant effect of Ebselen (PZ 51): peroxidase mimetic activity on phospholipid and cholesterol hydroperoxides vs free radical scavenger activity. Arch Biochem Biophys 1992;295:404–409
  • Bień M, Błaszczyk B, Kalinowska K, et al. Antifungal activity of 2-(4-chlorophenyl)-1,2-benzisoselenazol-3(2H)-one, the analog of Ebselen. Arch Immunol Ther Exp (Warsz) 1999;47:185–193
  • Pietka-Ottlik M, Wojtowicz-Mlochowska H, Kolodziejczyk K, et al. New organoselenium compounds active against pathogenic bacteria, fungi and viruses. Chem Pharm Bull 2008;56:1423–1427
  • Wójtowicz H, Chojnacka M, Młochowski J, et al. Functionalized alkyl and aryl diselenides as antimicrobial and antiviral agents: synthesis and properties. Farmaco 2003;58:1235–1242
  • Kumar BS, Tiwari SK, Saikant R, et al. Antibacterial and ulcer healing effects of organoselenium compounds in naproxen induced and Helicobacter pylori infected Wistar rat model. J Trace Elem Med Biol 2010;24:263–270
  • Holl V, Coelho D, Silbernagel L, et al. Prevention of nitrogen mustard-apoptosis in normal and transformed lymphocytes by ebselen. Biochem Pharmacol 2000;60:1565–1577

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.